Asco: Follow Up Of Lifileucel Treatment Abstract No : 10006 Indication : Melanoma Intervention : lifileucel (LN-144) Company : Iovance Biotherapeutics, Inc. Technology : TIL...
ESMO Abstracts
April 5, 2021 by Ankit Nigam
ASCO Abstracts ASCO: Lisocabtagene maraleucel (liso-cel) Abstract No : 8040 Indication : Non-Hodgkin's Lymphoma (aggressive) Intervention : Lisocabtagene maraleucel Company : Juno Therapeutics, a Bristol-Myers...